Gutknecht J L, Irthum B, Cavaroc G, Halberstadt J, Planchon E, Greil P, Berard J P
Département d'anesthésie-réanimation, universitaire de Clermont-Ferrand.
Agressologie. 1990 Jun;31(6):340-3.
To prevent and treat the ischemic complications due to the vasospasm, this report suggest the management of aneurysmal subarachnoid haemorrhage by the association of antifibrinolytics (tranexamic acid) to lower the risk of rebleeding, calcium channel blockers (nimodipine), and the keeping of an effective total blood volume (thanks to volume expansion and dopamine). From 88 patients aged from 4 to 73, two thirds were admitted at latest 48 h after the aneurysmal rupture Emergency surgery was carried out in the case of a compressive hematoma, early surgery (between the first and the third day) on the grades I, II and III of Hunt and Hess without any signs of angiographic vasospasms (40% of this series), delayed surgery for the others (27.5%), 10% didn't undergo any surgery. Only three patients (3.4%) presented rebleeding leading to death. The features of the whole series are: 51% recovered without any after effects, 22% had mild neurological deficiency, 10% had severe neurological deficiency and 17% died after their release from hospital. This protocol allowed a decrease in the ischemic complications due to the vasospasm and in the rate of rebleeding during the waiting interval when an angiographic or a clinical vasospasm allowed no surgery.
为预防和治疗血管痉挛引起的缺血性并发症,本报告建议通过联合使用抗纤溶药物(氨甲环酸)以降低再出血风险、钙通道阻滞剂(尼莫地平)以及维持有效的总血容量(通过扩容和使用多巴胺)来管理动脉瘤性蛛网膜下腔出血。在88例年龄从4岁至73岁的患者中,三分之二在动脉瘤破裂后最迟48小时入院。对于有压迫性血肿的患者进行急诊手术,对于Hunt和Hess分级为I、II和III级且无血管造影显示血管痉挛迹象的患者在早期(第一天至第三天)进行手术(占本系列的40%),其他患者进行延迟手术(27.5%),10%的患者未接受任何手术。仅有3例患者(3.4%)发生再出血并导致死亡。整个系列的情况如下:51%的患者康复且无任何后遗症,22%有轻度神经功能缺损,10%有严重神经功能缺损,17%在出院后死亡。当血管造影或临床显示血管痉挛而无法进行手术时,该方案能够减少血管痉挛引起的缺血性并发症以及等待期间的再出血发生率。